Windtree establishes a fund of 500 million USD to purchase BNB as treasury assets.

robot
Abstract generation in progress

Biotechnology company Windtree Therapeutics (Nasdaq: WINT) has just announced the establishment of an equity capital limit of up to 500 million USD and signed a stock purchase agreement worth 20 million USD with Build and Build Corp. 99% of the total raised funds will be used to purchase BNB, serving the company's cryptocurrency treasury asset strategy.

This capital limit will not be utilized until shareholders approve the increase in the number of common shares allowed to be issued.

CEO Windtree stated that integrating new sources of capital is a necessary step to expand BNB holdings. The director of Build and Build Corp noted that the strategy of integrating BNB demonstrates a long-term vision in creating value for shareholders through digital assets.

Windtree, a company operating in the biotechnology sector, shifting strongly towards digital asset accumulation such as BNB, reflects an increasingly evident trend: more and more traditional businesses are turning to cryptocurrencies as part of their capital management and asset diversification strategies in the modern financial environment.

BNB2.63%
View Original
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Share
Comment
0/400
No comments
Trade Crypto Anywhere Anytime
qrCode
Scan to download Gate app
Community
English
  • 简体中文
  • English
  • Tiếng Việt
  • 繁體中文
  • Español
  • Русский
  • Français (Afrique)
  • Português (Portugal)
  • Bahasa Indonesia
  • 日本語
  • بالعربية
  • Українська
  • Português (Brasil)